Background & Objectives: Depression and anxiety are common mental health disorders around the world. This study aims to examine efficacy of eidetic image therapy in comparison to cognitive behavior therapy for treating depressive and anxiety disorders, and to compare the patients' dropout ratio in these therapies. Methods: This was a randomized controlled trial conducted from January through June 2021 in psychiatry department of Sir Ganga Ram hospital Lahore. Using DSM-5 diagnostic criteria, 60 adult patients with depressive and anxiety disorders were recruited and were randomly and equally assigned to experimental (eidetic image therapy) and control (cognitive behavior therapy) groups. These participants received respective therapies and followed. Beck Depression Inventory and Beck Anxiety Inventory were used at baseline and after conducting five therapy sessions. Paired t-test was used to compare the mean difference and p-value of <0.05 was considered statistically significant. Results: Descriptive analysis demonstrated a major difference in dropout numbers of eidetic image therapy (9; 30 %) and cognitive behavior therapy (25; 83 %). The efficacy of both interventions was statistically incomparable due to this excessive number of dropouts in control group. However, eidetic image therapy showed a significant difference (p<0.001) in pre and post therapy ratings; each patient exhibited a marked decline in depression/anxiety symptoms after taking 5 sessions. Conclusion: Eidetic imagery is a promising therapeutic utility for depressive and anxiety disorders. Cognitive behavior therapy is also an effective treatment methodology but this narrative is based on analysis of few cases.
Background & Objective: Screen time has now become a most concerned issue around the world due its negative effects on children' health. COVID-19 was declared as a pandemic by World Health Organization (WHO) during March 2022 and lockdown was one of the strategy to control disease transmission. This study aims to investigate whether this lockdown caused an increase in screen time and what are its effects on physical, emotional, and behavioral functioning of children. Methods: It was a cross-sectional study including a sample of 260 mothers of children aged 5–13 years from Karachi, Lahore and Islamabad, during March to June 2021. A google survey form was developed and participants were invited using a google link on social media, parents' groups, Whats app groups and school facebook pages. Screen time was measured in number of screen hours per day. Physical health was evaluated through body mass index (BMI) reports. Children's Emotional Adjustment Scale (CEAS) and Strengths & Difficulties Questionnaire (SDQ) were used for behavioral and emotional problems. Coefficient of correlation and t-test was used for examining the difference of means. Results: About 244 (94%) mothers reported that screen time of their children is significantly increased during COVID-19 lockdown. There was a negative relationship observed between screen time with temper and anxiety control (r= -0.13; p= 0.04). However, a positive relationship was found for hyperactivity (r= 0.74; p<0.001) and conduct problems (r= 0.18; p= 0.003). We found a gender difference for screen time (t= 4.39; p=0.001) and hyperactivity (t= 2.35; p= 0.02), where boys were more hyperactive than girls. No significant difference was obsereved for BMI and pro-social behavior. Conclusion: Screen time among children is considerably increased during lockdown and this is associated with low temper control, anxiety, hyperactivity, and conduct problems. Remedial strategies are required at national level; media and school authorities can play a vital role in this regard.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.